An open-label, randomized, parallel-group trial to examine the feasibility of implementing a software as medicine for alcohol dependence

OUSO Kazuhiro0 个研究点目标入组 40 人开始时间: 2021年5月25日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1.A person who is 20 years of age or older at the time of obtaining the consent
•2.A person diagnosed with alcohol dependence
•3.A person who has high or very high DRL (average daily alcohol intake is more than 60g for men and 40g for women during the past 14 days at each time point) both at screening and at the start of the intervention
•4.A person who could be treated in an outpatient setting
•5.A person who has not had serious difficulties in social and family life caused by drinking
•6.A person who has not had life-threatening or serious organ damage because of drinking
•7.A person who has not had alcohol withdrawal symptoms (such as hallucinations, convulsions, and tremors) that require any urgent treatments
•8.A person who has given the consents for participating in this study by their free will after being fully informed and understanding about this study
•9.A person who can communicate with clinical trial staffs
•10.A person who is willing to undergo the intervention at predetermined times and procedures and use the device under study
•11. A person who uses smartphone on a daily basis

•1.A person who had less than 6 heavy drinking days (HDDS: days drinking more than 60g for men and 40g for women ) in the four weeks before screening
•2.A person who had five consecutive days with not drinking alcohol in the four weeks before screening
•3.A person who underwent alcohol dependence treatment or participated in the support program for reducing alcohol intake or self-help group in the 4 weeks before screening
•4.A person who received other structured psychotherapy in the four weeks before screening
•5.A person with the complications of dementia and intellectual disability
•6.A person who took concomitant prohibited drugs in the 4 weeks before screening
•7.A person with a significant suicidal ideation at screening or at the start of the intervention
•8.A person determined to have significant suicide risk by the principal investigator or sub-physician
•9.A person who participated in any clinical trials in the four weeks before screening
•10.A person who does not have a fixed address and phone number
•11.A person who does not use an iPhone with iOS14.0 or later or Android with version 10 or later on a daily basis
•12.A person who the principal investigator or sub-physician considered unsuitable as a subject.

发起方

OUSO Kazuhiro